University of Padua   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Padua Italy (1922)

Organization Overview

First Clinical Trial
1997
NCT00570011
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Department of Cardiothoracic and Vascular Sciences, University of Padua | Department of Medical and Surgical Sciences, University of Padua, Italy | Department of Surgery, Oncology and Gastroenterology - DiSCOG University of Padua - Azienza Ospedaliera di Padova | Unit of Angiology, University Hospital of Padua, Italy | University Hospital of Padua, Italy | University of Padua | University of Padua Department of Biomedical Science, Neuromuscular Physiology Laboratory | Women's and Children's Health Department- AO- University of Padua

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 3)

Brain Diseases (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Ductus Arteriosus, Patent (Phase 3)

Embolism (Phase 3)

Esophageal and Gastric Varices (Phase 3)

Fibrosis (Phase 3)

Hemorrhage (Phase 2)

Hepatic Encephalopathy (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hepatoblastoma (Phase 3)

Hypertension (Phase 3)

Hypertension, Portal (Phase 3)

Liver Cirrhosis (Phase 3)

Liver Diseases (Phase 4)

Premature Birth (Phase 4)

Pulmonary Embolism (Phase 3)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Thromboembolism (Phase 3)

Thrombosis (Phase 3)

Venous Thromboembolism (Phase 3)

Venous Thrombosis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial APIs: 35